Literature DB >> 1958554

Cytochrome P-450 C21scc: one enzyme with two actions: hydroxylase and lyase.

P F Hall1.   

Abstract

Testis, adrenal, ovary and placenta contain a microsomal cytochrome P-450 that is capable of converting progesterone to androstenedione and pregnenolone to dehydroepiandrosterone. This conversion requires 17 alpha-hydroxylation followed by C17,20-lyase activity which are both catalyzed by this one protein. Gene cloning and Northern blotting reveal that, at least in man, the same gene is responsible for both testicular and adrenal enzymes. The enzyme was first purified from neonatal pig testis. Both the testicular and adrenal enzymes show a marked preference for the 5-ene substrate (pregnenolone) in keeping with the extensive use of the 5-ene pathway in that species. Affinity alkylation with 17 alpha-bromoacetoxyprogesterone reveals a conserved cysteine at the active site of the enzyme and confirms the conclusion that a single enzyme catalyzes both reactions. Under some circumstances the enzyme catalyzes only 17 alpha-hydroxylation to permit the formation of the C21 steroid cortisol. The regulation of lyase activity, i.e. the determination of the extent to which the second activity is expressed, results from the availability of P-450 reductase. No doubt the greater concentration of this protein in testicular as opposed to adrenal microsomes (x 3.5) is responsible for the production of androgens in the testis and cortisol in the adrenal. Testicular cytochrome b5 also specifically stimulates lyase activity and also causes the porcine enzyme to catalyze a new reaction, i.e. delta 16-synthetase, resulting in synthesis of the important pheromone androsta-4,16-dien-3-one from progesterone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958554     DOI: 10.1016/0960-0760(91)90272-7

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  11 in total

Review 1.  Defining adrenarche in the rhesus macaque (Macaca mulatta), a non-human primate model for adrenal androgen secretion.

Authors:  A J Conley; B C Moeller; A D Nguyen; S D Stanley; T M Plant; D H Abbott
Journal:  Mol Cell Endocrinol       Date:  2010-12-22       Impact factor: 4.102

2.  Effect of ovarian aging on androgen biosynthesis in a cynomolgus macaque model.

Authors:  K F Ethun; C E Wood; C R Parker; J R Kaplan; H Chen; S E Appt
Journal:  Climacteric       Date:  2011-08-24       Impact factor: 3.005

3.  Cytochrome P450 17A1 Interactions with the FMN Domain of Its Reductase as Characterized by NMR.

Authors:  D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2015-12-30       Impact factor: 5.157

4.  Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR.

Authors:  D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

5.  Direct regulation of androgen receptor activity by potent CYP17 inhibitors in prostate cancer cells.

Authors:  Harris S Soifer; Naira Souleimanian; Sijian Wu; Anatoliy M Voskresenskiy; Filiz Kisaayak Collak; Bekir Cinar; Cy A Stein
Journal:  J Biol Chem       Date:  2011-12-15       Impact factor: 5.157

6.  17alpha-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response.

Authors:  Robert D Bruno; Tony D Gover; Angelika M Burger; Angela M Brodie; Vincent C O Njar
Journal:  Mol Cancer Ther       Date:  2008-09       Impact factor: 6.261

7.  Androgen receptor inactivation contributes to antitumor efficacy of 17{alpha}-hydroxylase/17,20-lyase inhibitor 3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer.

Authors:  Tadas Vasaitis; Aashvini Belosay; Adam Schayowitz; Aakanksha Khandelwal; Pankaj Chopra; Lalji K Gediya; Zhiyong Guo; Hong-Bin Fang; Vincent C O Njar; Angela M H Brodie
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

Review 8.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

Review 9.  Functional Zonation of the Adult Mammalian Adrenal Cortex.

Authors:  Gavin P Vinson
Journal:  Front Neurosci       Date:  2016-06-15       Impact factor: 4.677

Review 10.  Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.

Authors:  Marisa Cabeza; Araceli Sánchez-Márquez; Mariana Garrido; Aylín Silva; Eugene Bratoeff
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.